Bret Jensen has been a market analyst for over 13 years, helping investors find big winners in the biotech sector. BRET specializes in the beta sector where investors have potentially high returns.
Brett leads the investment group. The Biotechnology Forum offers a model portfolio with his and his team’s favorites, 12-20 high upside biotech stocks, live chat, live chat to discuss trading ideas, weekly research and option trading. The group also offers market commentary and portfolio updates every weekend. learn more.
Analyst Disclosure:I/We have long positions that are beneficial in AMZN, BA, and BYRN stocks through stock ownership, options, or other derivatives. I wrote this article myself and it represents my own opinion. I have not received compensation for it (other than asking for alpha). There is no business relationship with the companies mentioned in this article.
We are seeking disclosure of alpha: Past performance does not guarantee future results. No recommendations or advice is provided as to whether an investment is suitable for a particular investor. The above views and opinions may not reflect what we ask for alpha in general. It is not a licensed securities dealer, broker, or US investment advisor or investment bank to seek Alpha. Our analysts are third party authors, including both professional and individual investors who may not be licensed or accredited by the laboratory or regulatory body.
